Associated Papers
A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling.
Marín-Quílez A et al.
Journal of Thrombosis and Haemostasis : Jth, 2022
Rare missense variants in Tropomyosin-4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding.
Stapley RJ et al.
Journal of Thrombosis and Haemostasis : Jth, 2022
Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia.
Pleines I et al.
The Journal of Clinical Investigation, 2017
Select a paper to view details